OOIR: Observatory of International Research

Papers

(The median citation count of Current Rheumatology Reports is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Kawasaki Disease: an Update	134
COVID-19 and Myositis: What We Know So Far	90
A Review of Complement Activation in SLE	66
Systemic Lupus Erythematosus in Children and Young People	59
New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO	56
Dissecting Fibroblast Heterogeneity in Health and Fibrotic Disease	54
Pathogenesis of Giant Cell Arteritis and Takayasu Arteritis—Similarities and Differences	54
T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update	50
Diagnostic Value of Muscle Ultrasound for Myopathies and Myositis	49
Epidemiology of Antiphospholipid Syndrome in the General Population	47
Update on Imaging-Based Measurement of Bone Mineral Density and Quality	44
Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides	42
Nanotechnological Strategies for Osteoarthritis Diagnosis, Monitoring, Clinical Management, and Regenerative Medicine: Recent Advances and Future Opportunities	40
From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention	36
The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency	36
New Criteria for Lupus	35
Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease	32
Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope	32
Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory Component	31
The Use of COVID-19 Vaccines in Patients with SLE	31
Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics	30
Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis—a Complex Field with Significant Potential for Future Treatments	30
Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?	29
Current Epidemiology and Risk Factors for the Development of Hand Osteoarthritis	28
NETs in APS: Current Knowledge and Future Perspectives	28

Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens	27
Work Disability in Axial Spondyloarthritis	26
The Role of Musculoskeletal Ultrasound in the Rheumatoid Arthritis Continuum	26
How to Interpret Antiphospholipid Laboratory Tests	25
Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa	24
Complexities in Genetics of Psoriatic Arthritis	23
Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides	23
Lupus Vasculitis	23
Imaging in Vasculitis	23
Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials	23
The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis	22
Reactive Arthritis: Treatment Challenges and Future Perspectives	22
Re-Examining Myofascial Pain Syndrome: Toward Biomarker Development and Mechanism-Based Diagnostic Criteria	22
Involvement of Macrophages and Spinal Microglia in Osteoarthritis Pain	22
Management of Non-criteria Manifestations in Antiphospholipid Syndrome	22
An Update on the Diagnosis and Management of Lupus Nephritis	21
Advances in the Treatment of Behcet’s Disease	21
Etiologies of Rheumatoid Arthritis: Update on Mucosal, Genetic, and Cellular Pathogenesis	21
Pregnancy Outcomes in Systemic Vasculitides	20
Utility of Ultrasound and Dual Energy CT in Crystal Disease Diagnosis and Management	20
Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy	20
Dietary and Lifestyle-Centered Approach in Gout Care and Prevention	20
Treatment of Axial Spondyloarthritis: What Does the Future Hold?	20
MicroRNAs in Systemic Lupus Erythematosus: a Perspective on the Path from Biological Discoveries to Clinical Practice	20
T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis	19
An Update on Antiphospholipid Syndrome	19
Gut Microbiota in Lupus: a Butterfly Effect?	19
SARS-CoV-2 and Systemic Lupus Erythematosus	18
A White Paper on Collagen Hydrolyzates and Ultrahydrolyzates: Potential Supplements to Support Joint Health in Osteoarthritis?	18
Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future	18
Metabolic Regulation of Tendon Inflammation and Healing Following Injury	18
Adipocytic Progenitor Cells Give Rise to Pathogenic Myofibroblasts: Adipocyte-to-Mesenchymal Transition and Its Emerging Role in Fibrosis in Multiple Organs	18
Updates on the Immunopathology in Idiopathic Inflammatory Myopathies	18
Mitochondria in the Pathogenesis of Systemic Lupus Erythematosus	17
Pediatric APS: State of the Art	17
Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis	17
Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections)	16
Acupuncture and Chronic Musculoskeletal Pain	16
Axial Psoriatic Arthritis	16
Hyperuricemia, Gout, and the Brain—an Update	16
The Role of Antiphospholipid Antibodies in COVID-19	16
Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist	15
Novel Therapies for ANCA-associated Vasculitis	15
Vasculitides in HIV Infection	15
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis	15
JAK Inhibitors: What Is New?	15
Complementary and Alternative Medicine Use in Rheumatoid Arthritis	15
Impact and Management of Dysphagia in Inflammatory Myopathies	14
COVID-19 and Disease-Modifying Anti-rheumatic Drugs	14
Treatment of Calcinosis in Juvenile Dermatomyositis	14

Imaging of Joint and Soft Tissue Involvement in Systemic Lupus Erythematosus	14
JAK Inhibitors for Axial Spondyloarthritis: What does the Future Hold?	14
Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment	14
Exogenous miRNA: A Perspective Role as Therapeutic in Rheumatoid Arthritis	14
Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey	14
Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?	14
Self-Management of Rheumatoid Arthritis: Mobile Applications	14
The Musculoskeletal Manifestations of Marfan Syndrome: Diagnosis, Impact, and Management	13
IgA Vasculitis in Adults: a Rare yet Challenging Disease	13
An Update on the Pathogenesis of Skin Damage in Lupus	13
Vaccination for Children on Biologics	13
Cardiovascular Manifestations of Systemic Vasculitides	13
Update on Uric Acid and the Kidney	13
ANCA Status or Clinical Phenotype — What Counts More?	13
Modification of Gut Microbiota in Inflammatory Arthritis: Highlights and Future Challenges	13
Mesangial Cells in Lupus Nephritis	13
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management	12
The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature	12
NETosis in Rheumatic Diseases	12
A Spotlight on Drug-Induced Vasculitis	12
Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma	12
Persistent Joint Pain Following Arthropod Virus Infections	12
TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals	12
Turning the Page in Osteoarthritis Assessment with the Use of Ultrasound	11
An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice	11
Polymyalgia Rheumatica: a Common Disease in Seniors	11
Calcinosis in Systemic Sclerosis: Updates in Pathophysiology, Evaluation, and Treatment	11
Microbial Influences of Mucosal Immunity in Rheumatoid Arthritis	11
Opioid Use and Total Joint Replacement	11
Beyond Giant Cell Arteritis and Takayasu’s Arteritis: Secondary Large Vessel Vasculitis and Vasculitis Mimickers	11
Spectrum of Spondyloarthritis Among Chinese Populations	10
Worldwide Differences in Clinical Phenotype of Axial Spondyloarthritis	10
Autonomic Nervous System Dysregulation and Osteoarthritis Pain: Mechanisms, Measurement, and Future Outlook	9
Radiological Findings of the Cervical Spine in Rheumatoid Arthritis: What a Rheumatologist Should Know	9
Morbidity and Mortality of Large-Vessel Vasculitides	9
Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis	9
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update	9
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)	9
Drivers of Inflammation in Psoriatic Arthritis: the Old and the New	9
Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis	9
Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease	9
Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMAN	9
Enthesitis in Psoriatic Arthritis, the Sonographic Perspective	9
Emergence of Musculoskeletal Ultrasound Use in Pediatric Rheumatology	9
What Has Dual Energy CT Taught Us About Gout?	9
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms	9
Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis	8
Differential Metabolome in Rheumatoid Arthritis: a Brief Perspective	8
Sonographic Features of Salivary Glands in Sjögren’s Syndrome and its Mimics	8
Localized Forms of Vasculitis	8
Trabecular Bone Score in Rheumatic Disease	8
COVID-19: What Do Rheumatologists Need to Know?	8
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis	8
Neurosarcoidosis: Phenotypes, Approach to Diagnosis and Treatment	8
State of the Art Management of Aortic Valve Disease in Ankylosing Spondylitis	8
Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis	8
Anatomical Joint Form Variation in Sacroiliac Joint Disease: Current Concepts and New Perspectives	8